Body distribution and stability studies on mitoxantrone loaded solid lipid nanoparticles conjugated with concanavalin- A

International Journal of Pharmacy and Pharmaceutical Sciences

Volumn 2, Issue 2, 2010, Pages 39-42

  Mahor, Alok ^a   Alok, Shashi ^b   Gupta, Yashwant ^a   Jain, S K ^a  

^a DR H S GOUR UNIVERSITY   (India)

^b BUNDELKHAND UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CONCANAVALIN A; MITOXANTRONE; SOLID LIPID NANOPARTICLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG STABILITY; DRUG STORAGE; DRUG TISSUE LEVEL; DRUG URINE LEVEL; MALE; MOUSE; NONHUMAN; PARTICLE SIZE; TISSUE DISTRIBUTION; TUMOR;

EID: 77953451163     PISSN: None     EISSN: 09751491     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Joseph Panno, Cancer, the role of genes, lifestyle and environment, Library of Congress Cataloging, 2005; 8-155
2. Peppas L. B., Blanchette J. O., Nanoparticle and targeted systems for cancer therapy, Advanced Drug Delivery Reviews, 2004; 56: 1649-1659
3. Durr, F. E. Biologic and biochemical effects of mitoxantrone, Seminar on Oncology 1984; 11: 3-10.
4. Burns, C. P., Haugstad, B. N., Mossmann, C. J., North, J. A. and Ingraham, L. M., Membrane lipid alteration: Effect on cellular uptake of mitoxantrone, Lipids, 1988; 23: 393-397.
5. Vyas S.P. and Khar R.K., Targeted and Controlled Drug Delivery, CBS publishers and Distributors, New Delhi, 2002; First Edition:512-515
6. Muller R.H., Mehnert W., Lucks J.S., Schwarz C., Muhlen A. Z, Weyhers H., Freitas C., Ruhl D., Solid lipid Nanoparticles, An alternative colloidal carrier system for controlled drug delivery, European Journal of Pharmaceutics and Biopharmaceutics, 1995; 41: 62-69
7. H. Weyhers, S. Ehlers, H. Hahn, E. B. Souto, R. H. Muller, Solid Lipid Nanoparticles (SLN), Effects of lipid composition on in vitro degradation and in vivo toxicity, Pharmazie, June 2006; 61: Issue 6: 539-544
8. Vasir, J. K., Labhasetwar, V., Targeted Drug Delivery in Cancer, Technology in Cancer Research and Treatment, 2005; 4: 363-374
9. Wissing S.A., Kayserb O., Muller R.H., Solid lipid nanoparticles for parenteral drug delivery, Advanced Drug Delivery Reviews, 2004; 56: 1257-1272
10. Inbar M., Sachs L., Interaction of the carbohydrate-binding protein Concanavalin A with normal and transformed cells, Weizmann institute of science, Rehovot, Israel, 1969; 1-8
11. Naeem, Aabgeena; Saleemuddin, M.; Hasan Khan, Rizwan, Glycoprotein Targeting and Other Applications of Lectins in Biotechnology, Current Protein and Peptide Science, June 2007; Volume 8: Number 3: 261-271
12. Schubert M.A., Muller C.C., Goymann, Solvent injection as a new approach for manufacturing lipid nanoparticles, evaluation of the method and process parameters, European Journal of Pharmaceutics and Biopharmaceutics, 2003; 55: 125-131